PMN compared with IMMX: revenue, margins and what each company keeps, and the suppliers and customers both name

PMNProMIS Neurosciences Inc.

Mkt capRevenueRevenue

IMMXImmix Biopharma, Inc.

Mkt capRevenueRevenue

Compare

PMNProMIS Neurosciences Inc.

IMMXImmix Biopharma, Inc.

Price

Mkt cap

Revenue

Revenue flow

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

PMNProMIS Neurosciences Inc.

3.46▼−68.74%· post 3.77

Mkt cap$29.7M

IMMXImmix Biopharma, Inc.

7.67▼−3.84%· post 7.67

ClosedOct 30 '26

Mkt cap$549.4M

Compare

ClosedOct 30 '26

PMNProMIS Neurosciences Inc.

IMMXImmix Biopharma, Inc.

3.46▼−68.74%post 3.77

Price

7.67▼−3.84%post 7.67

$29.7M

Mkt cap

$549.4M

PMN3.46▼−68.74%vsIMMX7.67▼−3.84%ClosedOct 30 '26

rebased to 0%

PMN, solidIMMX, dashed

PMN: latest quarter not drawable. IMMX: latest quarter not drawable.Method ›

direct ties · both sidesSources ›

direct ties · both sides

No disclosed counterparties: PMN, IMMX.

Role chip = supplier or customerSource: SEC EDGAR